Pharmaceutical Advertising 2019

Last Updated: 11 June 2019

Pharmaceutical Advertising 2019 - Comparisons

  • {{chapter}}
Last Updated: 20 February 2019

Contributors:
Kim & Chang
(Law and Practice)


Choose topics
( )

Table of contents

SECTION: Law and Practice (by Kim & Chang)

Contributors:
Kim & Chang
(Law and Practice)


About the contributors:
Kim & Chang

brings together in its health practice the firm's unparalleled regulatory, intellectual property, corporate, competition law and litigation expertise to meet the complex needs of clients in the pharmaceutical, animal health, medical device and diagnostics sectors. Formed when Kim & Chang was first ... established in 1973, the practice has since advised the great majority of multinational firms in these sectors that do business in Korea, from established industry leaders to newer biotech companies and start-ups. Considerable knowledge of how regulatory agencies work and how the relevant laws and law enforcement trends have evolved allow the practice to advise clients proactively on a wide range of issues, from the legality of specific promotional practices, product approval and pricing to product recalls, anti-counterfeiting strategies, advertising claims and regulatory compliance. The highly experienced team – comprised not only of attorneys but industry specialists and numerous former officials of the Ministry of Health & Welfare (MOHW), the Ministry of Food & Drug Safety (formerly the Korea Food and Drug Administration, MFDS), and other government agencies – has an in-depth, practical understanding of the commercial and regulatory aspects of these businesses that is unmatched in Korea.